|
A concerning and dangerous trend is spreading around social media: breathing in hydrogen peroxide through nebulizers to try to prevent or treat COVID-19. Nebulizing hydrogen peroxide is not safe, and it will not treat COVID-19. Read AAFA's statement and learn more about proven ways you can protect yourself from COVID-19.
|
|
|
Is ragweed pollen trying to threaten your fall plans? Ragweed pollen counts are peaking across the United States, making many people miserable. But the more you know about ragweed pollen, the better you can fight allergy symptoms. Learn ways to find relief this fall. |
|
|
|
Hispanic groups, especially Puerto Rican Americans, face higher rates of asthma, asthma attacks, emergency room visits, and death. Read this spotlight from our “Asthma Disparities in America” report to learn more about asthma disparities in Hispanic Americans and how we can improve asthma care.
|
|
|
Now that COVID-19 has been around a while schools have adapted for in-person learning. We've updated our COVID-19 and Asthma Toolkit for Schools with a new school year and new recommendations in mind. Download your copy to print or share!
|
|
|
October is National Indoor Air Quality Awareness Month. All next month, we'll share tips for improving your indoor air and reducing your exposure to asthma triggers and allergens. During October, we invite you to join us in a Healthier Home challenge.
Using our interactive Healthier Home, pick one area of your home each week. Follow the checklist for that area to see how many ways you can make your home healthier! While you're at it, check out our CERTIFIED asthma & allergy friendly® products and services. We test household products and services against strict standards to make sure they can help you make your home healthier.
|
|
|
|
The latest results in a clinical trial for the Pfizer-BioNTech COVID-19 vaccine for ages 5-11 has had positive results. Learn more about the trial.
|
|
|
|
The Food and Drug Administration (FDA) has issued an emergency use authorization for Pfizer-BioNTech COVID-19 vaccine booster shots for specific groups. They have recommended third booster shots for people 65 and older, people 18 – 64 who are at high risk of severe COVID-19, and people 18 – 64 who are at higher risk because of frequent institutional or occupational exposure. Read more about the recommendations.
|
|
|
|
The FDA issued a statement outlining the steps they will take to ensure COVID-19 vaccines are safe and effective for young children. Read the press release from the FDA.
|
|
|
If you missed the live stream of the Little Airways Big Voices PFDD meeting on asthma in childhood – hosted by AAFA and other patient advocacy organizations – you can watch the recording. During the meeting, patients, caregivers, and advocates shared experiences with asthma in childhood with FDA representatives and other key stakeholders. This meeting is an important part of the process to develop new treatment options. Watch now.
You can still send in your comments and experiences living with and managing asthma in childhood through Oct. 20, 2021.
|
|
|
|
Around 60 million people in the U.S. have asthma and allergies. That’s more than diabetes, cancer, coronary heart disease, Alzheimer’s, and Parkinson’s combined. Through a donation to the Asthma and Allergy Foundation of America, you can improve the lives of people with asthma and allergies. Your gift allows us to continue to offer life-saving information, support, advocacy, and research to the millions managing these conditions every day. Your donation, no matter how small, makes a difference. Thank you!
|
|
|
Attention health care providers, respiratory therapists, asthma educators, and nurses: Join us on Wednesday, Oct. 13, 2021, at 1 p.m. ET for a webinar called, “Challenges of Medication Applications” – presented by Lorene Alba, AE-C, Director of Education for AAFA, and sponsored by Vitalograph®.
The goal of this program is to help you understand:
- How to properly use asthma devices
- How to determine the best asthma delivery device
- How to incorporate health literacy into all your resources
- How to use the teach-back method
This program is pending for 1.0 contact hours of Continuing Respiratory Care Education (CRCE) credits by the American Association for Respiratory Care.
|
|
|
More than just a skin disease, chronic spontaneous urticaria (CSU) causes sleep issues, fatigue, pain, anxiety, and depression. Limited treatment options make disease management a challenge for doctors and patients.
If you are a health care professional treating someone with CSU, join us for the “Chronic Spontaneous Urticaria: New Hope With Emerging Targeted Agents” session tomorrow, Sept. 24, at 2 p.m. ET.
This free, interactive online continuing medical education (CME) course is hosted by AAFA, PlatformQ Health, and ImmunologyLive. This course will cover:
- The latest in CSU treatment options
- Management and treatment escalation standards
- Perspectives from the patient journey
|
|
|
|
|
